Inhibition of HDAC6 using TubA improves skeletal muscle disorders in Duchenne Muscular Dystrophy (DMD) by modulating TGF-β signaling (Osseni et al., 2022). Here, DNMBP is linked to Duchenne muscular dystrophy.